Harmonized AS/MQ Efficacy Study - Thailand

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Malaria
Interventions
DRUG

Artesunate/mefloquine (AS/MQ)

"* artesunate (AS) 4mg/kg by mouth once daily at 0, 24 and 48 hours~* mefloquine (MQ) 15mg/kg by mouth once at 72 hours, and 10mg/kg once by mouth at 84-96 hours~* primaquine (PQ) 0.5mg/kg single dose by mouth at 84-96 hours"

Trial Locations (1)

71240

Kwai River Christian Hospital in Sangklaburi, Thong Pha Phum

All Listed Sponsors
collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

Global Emerging Infections Surveillance and Response System

FED

lead

Armed Forces Research Institute of Medical Sciences, Thailand

OTHER_GOV

NCT02052323 - Harmonized AS/MQ Efficacy Study - Thailand | Biotech Hunter | Biotech Hunter